A transaction-focused guide to gastroenterology practice valuation multiples, connecting operating evidence, buyer underwriting, transaction risk, and seller outcomes.
An in-depth guide to physical therapy practice valuation, including buyer-accepted EBITDA, clinic-level economics, payer and referral risk, valuation methods, and the bridge from enterprise value to seller proceeds.
A buyer-underwriting guide to fertility clinic valuation, including IVF cycle volume, patient and payer mix, physician and embryology capacity, lab economics, reported-to-normalized-to-buyer-accepted EBITDA, free cash flow, valuation methods and multiple logic, ownership and transferability, enterprise value, equity value, diligence repricing, financing constraints, and seller proceeds.
A buyer-focused guide to medical supply company valuation, including normalized and buyer-accepted EBITDA, valuation methods, inventory and working capital, reimbursement, enterprise-to-equity value, and seller proceeds.
A buyer-underwriting guide to healthcare software company valuation, including recurring revenue, retention, customer cohorts, gross margin, implementation burden, product economics, normalized EBITDA, free cash flow, valuation methods, financing, structure, and seller proceeds.
By George Barsom, JD, CM&AA®, CAIA® • Last updated: July 12, 2026 Updated for ambulatory surgery center owners, physician investors, health systems, strategic operators, private equity sponsors, lenders, attorneys, accountants, and transaction professionals evaluating ASC fair market value, normalized EBITDA, case economics, ownership interests, real estate, risk, transaction structure, and seller proceeds. Key answer: an ambulatory surgery…
A buyer-underwriting guide to urgent care business valuation, including trusted revenue, clinic cohorts, provider capacity, payer economics, occupational medicine, ancillary diagnostics, four-wall performance, normalized EBITDA, free cash flow, valuation methods, financing, structure, and seller proceeds.
A buyer-led guide to behavioral health company valuation covering revenue quality, payer and authorization risk, census durability, clinician capacity, normalized EBITDA, compliance, valuation methods, lender underwriting, deal structure, and seller proceeds across mental health, ABA, autism services, pediatric therapy, I/DD, and substance use treatment.
By George Barsom, JD, CM&AA®, CAIA® • Last updated: June 23, 2026 Updated for behavioral-health owners evaluating normalized EBITDA, revenue and census quality, payer and authorization exposure, clinician capacity, compliance, add-on versus platform positioning, financing capacity, deal structure, and seller proceeds across mental health, ABA, autism services, pediatric therapy, I/DD, substance use treatment, and related care models….
A buyer-led guide to medspa valuation covering normalized EBITDA, cash-pay revenue quality, patient retention, service mix, provider dependence, medical oversight, valuation methods, seller proceeds, and transaction readiness.